Artificial intelligence retinal screening solution seeking partners via distribution service agreement

The company, based in Singapore, specialises in the development and deployment of AI deep learning systems in the healthcare industry. The company has developed an automated system that is able to detect 3 retina diseases concurrently. Through analysis of digital colour retina images, the system is able to identify signs of diabetic retinopathy, glaucoma and age-related-macular degeneration.
Cooperación Empresarial
Enlace: Artificial intelligence retinal screening solution seeking partners via distribution service agreement